PRISCILLA PAGE: Open Payments
NPI 1689196412 · DALLAS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,932 in 60 payments from 9 companies in 2025. Trend: 2023 $3,097 · 2024 $2,919 · 2025 $1,932
Food & beverage: $1,932
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 17 | $540 |
| Janssen Biotech, Inc. | 10 | $475 |
| Takeda Pharmaceuticals U.S.A., Inc. | 14 | $404 |
| Janssen Scientific Affairs, LLC | 2 | $167 |
| Lilly USA, LLC | 5 | $124 |
| Organon LLC | 5 | $77 |
| Aimmune Therapeutics, Inc. | 3 | $66 |
| PFIZER INC. | 3 | $57 |
| Celltrion USA Inc. | 1 | $21 |
Products named: TREMFYA, ENTYVIO, SKYRIZI, RINVOQ, OMVOH, GATTEX, HADLIMA, VOWST.
Industry payments across TX — which companies pay providers there.
